Top Markets
Coin of the day
Proteomics International Laboratories Ltd. Proteomics International Laboratories Ltd.

Proteomics International Laboratories Ltd.

PIQ
Classificação em ações #30135
Proteomics International Laboratories Ltd operates as a medical technology... Proteomics International Laboratories Ltd operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and Southeast Asia. It provides PromarkerD, a blood test to predict diabetic kidney disease (DKD). The company’s products under development include PromarkerEndo, which has completed clinical validation phase for endometriosis diagnosis; PromarkerEso, which has completed clinical validation trials for esophageal cancer diagnosis; and OxiDx (2-tag), which has completed clinical validation phase for oxidative stress treatment. It is also developing diagnostic tests for that includes DKD - T1D, that is under clinical phase for type 1 diabetes, diabetic retinopathy, and diabetic neuropathy; Asthma and COPD, which has completed proof-of-concept study trials for asthma and chronic obstructive pulmonary disease; Plant Dieback, that is under development phase for phytophthora dieback; Diabetic Retinopathy, which has completed discovery phase for sight-threatening retinopathy; and Diabetic Neuropathy, that is under research phase to investigate predictive biomarkers for diabetic neuropathy. The company also offers analytical services, such as specialist contract research focusing on biomarker discovery, biosimilars quality control, and pharmacokinetic testing for clinical trials. It has strategic collaboration with Harry Perkins Institute of Medical Research, Bioplatforms Australia, The University of Western Australia, Australian Research Council Training Centre, and the Australian Centre. Proteomics International Laboratories Ltd was founded in 2001 and is based in Perth, Australia.
Preço da ação
$0.11284557
Valor de mercado
$18.66M
Variação (1 dia)
3.23%
Variação (1 ano)
-47.82%
País
AU
Negociar Proteomics International Laboratories Ltd. (PIQ)

Categoria

Preço PIQ com a capitalização de mercado de B
Proteomics International Laboratories Ltd. Proteomics International Laboratories Ltd.
PIQ
$0.11284557
Capitalização de mercado de Proteomics International Laboratories Ltd.(PIQ)
Valor de mercado: $18.66M
Em August 2026, Proteomics International Laboratories Ltd. tem uma capitalização de mercado de $18.66M. Isso faz com que Proteomics International Laboratories Ltd. seja a 30135th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Proteomics International Laboratories Ltd. de 2014 a 2026
PIQ comparado com o topo de 5 mais populares stocks
Preço para PIQ Ativo B Capitalização de mercado de B Resultados
Proteomics International Laboratories Ltd. Proteomics International Laboratories Ltd.
$32,088.54 $18.66M
$5.307T +28,435,703.91%
Proteomics International Laboratories Ltd. Proteomics International Laboratories Ltd.
$27,517.98 $18.66M
$4.551T +24,385,418.74%
Proteomics International Laboratories Ltd. Proteomics International Laboratories Ltd.
$25,121.16 $18.66M
$4.154T +22,261,441.99%
Proteomics International Laboratories Ltd. Proteomics International Laboratories Ltd.
$21,699.71 $18.66M
$3.589T +19,229,460.39%
Proteomics International Laboratories Ltd. Proteomics International Laboratories Ltd.
$16,912.35 $18.66M
$2.797T +14,987,063.56%